Skip to main content

Adverum Biotechnologies, Inc. (ADVM)

NASDAQ: ADVM · IEX Real-Time Price · USD
1.87 -0.07 (-3.61%)
Nov 29, 2021 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012
Revenue
00.251.611.851.462.320.570.480.03
Revenue Growth
--84.49%-12.82%27.08%-37.26%305.42%19.17%1500.00%-
Gross Profit
00.251.611.851.462.320.570.480.03
Selling, General & Admin
44.6428.3824.5620.8624.3622.1181.780.54
Research & Development
73.3140.4250.1339.8431.6725.4616.982.151.31
Other Operating Expenses
005060.712.57000
Operating Expenses
117.9568.879.6960.7116.7450.1424.973.931.85
Operating Income
-117.95-68.55-78.08-58.85-115.28-47.82-24.4-3.45-1.82
Interest Expense / Income
0000000.020.070.01
Other Expense / Income
-1.56-4.06-4.2-2.7-0.76-0.370.981.75-0.01
Pretax Income
-116.39-64.49-73.88-56.15-114.52-47.45-25.4-5.28-1.81
Income Tax
1.110-1.250-0.780000
Net Income
-117.51-64.49-72.63-56.15-113.75-47.45-25.4-5.28-1.81
Preferred Dividends
0000003.2300
Net Income Common
-117.51-64.49-72.63-56.15-113.75-47.45-28.63-5.28-1.81
Shares Outstanding (Basic)
8564614436251244
Shares Outstanding (Diluted)
8564614436251244
Shares Change
32.83%4.44%40.57%20.46%42.26%118.69%217.21%0.82%-
EPS (Basic)
-1.38-1.01-1.18-1.29-3.14-1.86-2.46-1.44-0.50
EPS (Diluted)
-1.38-1.01-1.18-1.29-3.14-1.86-2.46-1.44-0.50
Free Cash Flow Per Share
-1.07-1.07-0.89-1.06-1.13-1.50-0.57-0.62-0.35
Gross Margin
-100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
--27418.00%-4843.73%-3182.64%-7923.30%-2062.23%-4266.08%-719.58%-6053.33%
Profit Margin
--25794.40%-4505.40%-3036.61%-7817.66%-2046.27%-4441.26%-1099.17%-6036.67%
Free Cash Flow Margin
--27366.80%-3397.83%-2511.47%-2802.61%-1652.87%-1152.27%-472.08%-4233.33%
Effective Tax Rate
-0.96%0.00%1.69%0.00%0.68%0.00%0.00%0.00%0.00%
EBITDA
-112.24-62.91-72.13-54.05-112.92-46.64-25.22-5.18-1.8
EBITDA Margin
--25165.20%-4474.38%-2923.26%-7760.76%-2011.25%-4409.79%-1078.54%-6006.67%
EBIT
-116.39-64.49-73.88-56.15-114.52-47.45-25.39-5.2-1.8
EBIT Margin
--25794.40%-4582.94%-3036.61%-7870.93%-2046.27%-4438.11%-1083.96%-6010.00%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).